Reckitt Benckiser Pharmaceuticals Inc. to Voluntarily Discontinue the Supply of Suboxone Tablets (buprenorphine and naloxone sublingual tablets [CIII])

September 25, 2012 — Reckitt Benckiser Pharmaceuticals Inc. confirms that it notified the U.S. Food and Drug Administration (FDA) on September 18, 2012 that the company is voluntarily discontinuing the supply of Suboxone Tablets in the US… (Source: Drugs.com – Pharma News)